journal article·2011-11

Treatment with iron oxide nanoparticles induces ferritin synthesis but not oxidative stress in oligodendroglial cells

Michaela C. Hohnholt, Mark Geppert, Ralf Dringen

Acta Biomaterialia· Volume 7· Issue 11
Publisher page

Abstract

Magnetic iron oxide nanoparticles (IONPs) have been used for a variety of neurobiological applications, although little is yet known as to the fate of such particles in brain cells. To address these questions, we have exposed oligodendroglial OLN-93 cells to dimercaptosuccinate-coated IONPs. Treatment of the cells strongly increased the specific cellular iron content proportional to the IONP concentrations applied (0-1000 μM total iron as IONPs) up to 300-fold, but did not cause any acute cytotoxicity or induce oxidative stress. To investigate the potential of OLN-93 cells to liberate iron from the accumulated IONPs, we have studied the upregulation of the iron storage protein ferritin and the cell proliferation as cellular processes that depend on the availability of low-molecular-weight iron. The presence of IONPs caused a concentration-dependent increase in the amount of cellular ferritin and partially bypassed the inhibition of cell proliferation by the iron chelator deferoxamine. These data demonstrate that viable OLN-93 cells efficiently take up IONPs and suggest that these cells are able to use iron liberated from accumulated IONPs for their metabolism.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Iron Metabolism and Disorders · Trace Elements in Health · Alzheimer's disease research and treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (63)

Show source-provided references
1. Nanotechnology, nanotoxicology, and neuroscience10.1016/j.pneurobio.2008.09.009 ↗
2. Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review10.1038/jcbfm.2009.192 ↗
3. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors10.1016/j.biomaterials.2007.08.050 ↗
4. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma10.1007/s11060-005-9059-z ↗
5. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination10.1073/pnas.96.26.15256 ↗
6. Pharmacokinetic parameters and tissue distribution of magnetic Fe3O4 nanoparticles in mice
7. Toxic potential of materials at the nanolevel10.1126/science.1114397 ↗
8. Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate10.1046/j.1471-4159.2003.02236.x ↗
9. Oxidative stress and iron homeostasis: mechanistic and health aspects10.1080/10408360701713104 ↗
10. Iron from nanocompounds containing iron and zinc is highly bioavailable in rats without tissue accumulation10.1038/nnano.2010.79 ↗
11. Tuning cell cycle regulation with an iron key10.4161/cc.6.16.4603 ↗
12. Iron-sulfur cluster biogenesis and human disease10.1016/j.tig.2008.05.008 ↗
13. Effects of iron chelators, iron salts, and iron oxide nanoparticles on the proliferation and the iron content of oligodendroglial OLN-93 cells10.1007/s11064-010-0184-5 ↗
14. Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation10.1182/blood.V64.3.748.748 ↗
15. Relationship of iron to oligodendrocytes and myelination10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7 ↗
16. Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain10.1002/cne.903380108 ↗
17. The life, death, and replacement of oligodendrocytes in the adult CNS10.1111/j.1471-4159.2008.05570.x ↗
18. Oligodendrocytes: biology and pathology10.1007/s00401-009-0601-5 ↗
19. Internalisation of engineered nanoparticles into mammalian cells in vitro: influence of cell type and particle properties10.1007/s11051-010-0030-3 ↗
20. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells10.1038/nbt1201-1141 ↗
21. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging10.1002/nbm.970 ↗
22. Degradability of superparamagnetic nanoparticles in a model of intracellular environment: follow-up of magnetic, structural and chemical properties10.1088/0957-4484/21/39/395103 ↗
23. Intracellular nanoparticle coating stability determines nanoparticle diagnostics efficacy and cell functionality10.1002/smll.201000763 ↗
24. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles10.1016/j.biomaterials.2009.03.032 ↗
25. In vitro evaluation of magnetic resonance imaging contrast agents for labeling human liver cells: implications for clinical translation10.1007/s11307-010-0405-y ↗
26. Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging10.1002/nbm.1038 ↗
27. OLN-93: a new permanent oligodendroglia cell line derived from primary rat brain glial cultures10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8 ↗
28. Accumulation of iron oxide nanoparticles by cultured brain astrocytes10.1166/jbn.2009.1033 ↗
29. Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes10.1088/0957-4484/22/14/145101 ↗
30. Fumaric acid dialkyl esters deprive cultured rat oligodendroglial cells of glutathione and upregulate the expression of heme oxygenase 110.1016/j.neulet.2010.03.048 ↗
31. Detoxification of exogenous hydrogen peroxide and organic hydroperoxides by cultured astroglial cells assessed by microtiter plate assay10.1016/S1385-299X(97)00047-0 ↗
32. Copper accumulation by cultured astrocytes10.1016/j.neuint.2009.12.002 ↗
33. Primary glial cultures as a model for studying hormone action10.1016/0076-6879(85)09097-8 ↗
34. Protein measurement with the Folin phenol reagent10.1016/S0021-9258(19)52451-6 ↗
35. Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells10.1016/j.ab.2004.03.049 ↗
36. Glutathione content as an indicator for the presence of metabolic pathways of amino acids in astroglial cultures10.1046/j.1471-4159.1996.67041375.x ↗
37. Free radicals and antioxidants in normal physiological functions and human disease10.1016/j.biocel.2006.07.001 ↗
38. The pivotal role of astrocytes in the metabolism of iron in the brain10.1007/s11064-007-9375-0 ↗
39. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells10.1016/S0162-0134(02)00461-0 ↗
40. Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects10.2217/nnm.10.106 ↗
41. In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines10.1007/s00449-009-0354-5 ↗
42. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling10.1186/1743-8977-6-1 ↗
43. In vitro toxicity of nanoparticles in BRL 3A rat liver cells10.1016/j.tiv.2005.06.034 ↗
44. Oligodendroglial cells in culture effectively dispose of exogenous hydrogen peroxide: comparison with cultured neurones, astroglial and microglial cells10.1046/j.1471-4159.2002.00999.x ↗
45. Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes10.1523/JNEUROSCI.3989-03.2004 ↗
46. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion10.1523/JNEUROSCI.18-16-06241.1998 ↗
47. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles10.1038/nnano.2007.260 ↗
48. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling10.1016/j.biomaterials.2010.08.075 ↗
49. Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells10.1016/j.jinorgbio.2008.12.017 ↗
50. Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles, in vivo visualization by magnetic resonance imaging10.1186/1477-3155-9-4 ↗
51. Schmidtke-Schrezenmeier G, Urban M, Musyanovych A, Mailänder V, Rojewski M, Fekete N, et al. Labeling of mesenchymal stromal cells with iron oxide-poly(L-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effetcs on cellular function and magnetic resonance imaging properties. Cytotherapy, in press.
52. High intracellular iron oxide nanoparticle concentrations affect cellular cytoskeleton and focal adhesion kinase-mediated signaling10.1002/smll.200902084 ↗
53. Advanced biomaterials accumulation of citrate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes10.1002/adem.201080055 ↗
54. Superparamagnetic iron oxide-labeled Schwann cells and olfactory ensheathing cells can be traced in vivo by magnetic resonance imaging and retain functional properties after transplantation into the CNS10.1523/JNEUROSCI.3126-04.2004 ↗
55. Ferritins: a family of molecules for iron storage, antioxidation and more10.1016/j.bbagen.2008.09.004 ↗
56. Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: the effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake10.1002/jcp.1041610119 ↗
57. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation10.1097/00004647-200208000-00001 ↗
58. Long-circulating iron-oxides for MR imaging10.1016/0169-409X(95)00033-4 ↗
59. Docosahexaenoic acid-dependent iron accumulation in oligodendroglia cells protects from hydrogen peroxide-induced damage10.1111/j.1471-4159.2008.05234.x ↗
60. Halliwell · 2007
61. Evidence that desferrioxamine cannot enter cells by passive diffusion10.1016/0006-2952(91)90109-I ↗
62. Uptake of ferrous iron by cultured rat astrocytes10.1002/jnr.22217 ↗
63. The biochemistry of desferrioxamine and its relation to iron metabolism10.1111/j.1749-6632.1965.tb54077.x ↗